Chemical Structure (Ipratropium 01)
Ipratropium Bromide
Product Images NDC 0781-7157
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 0781-7157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Ipratropium 02)
Figure 2 (Ipratropium 03)
Figure 3 (Ipratropium 04)
Principal Display Panel (25 Ampule Carton)
Ipratropium Bromide Inhalation Solution is presented in a 0.02% solution with a 0.5mg strength, intended for oral inhalation only in 25 x 25mL unit-dose vials. Each vial contains a solution made up of Ipratropium Bromide 0.02%, preservative-free, and a sterile aqueous solution containing Sodium Chloride, adjusted to a pH of 3.4 with Hydrochloric Acid. Dosage instructions are not provided with the solution. The product should be stored at room temperature between 15°C and 30°C and protected from light.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
